BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29981073)

  • 1. Prevalence of latent tuberculosis infection in Syrian refugees to Canada.
    Warrington P; Tyrrell G; Choy K; Eisenbeis L; Long R; Cooper R
    Can J Public Health; 2018 Feb; 109(1):8-14. PubMed ID: 29981073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
    Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
    Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QuantiFERON-TB Gold Plus Is a More Sensitive Screening Tool than QuantiFERON-TB Gold In-Tube for Latent Tuberculosis Infection among Older Adults in Long-Term Care Facilities.
    Chien JY; Chiang HT; Lu MC; Ko WC; Yu CJ; Chen YH; Hsueh PR
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29793966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Step toward Tuberculosis Elimination in a Low-Incidence Country: Successful Diagnosis and Treatment of Latent Tuberculosis Infection in a Refugee Clinic.
    Rennert-May E; Hansen E; Zadeh T; Krinke V; Houston S; Cooper R
    Can Respir J; 2016; 2016():7980869. PubMed ID: 27445565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of healthcare workers for latent tuberculosis infection in the low tuberculosis burden country: QuantiFERON-TB gold in tube test or tuberculin skin test?
    Keshavarz Valian S; Mahmoudi S; Pourakbari B; Abdolsalehi MR; Eshaghi H; Mamishi S
    Arch Environ Occup Health; 2019; 74(3):109-114. PubMed ID: 30516445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of QuantiFERON tuberculosis gold-in-tube test for detecting latent tuberculosis infection among close household contacts of confirmed tuberculosis patients in Accra, Ghana.
    Mensah GI; Sowah SA; Yeboah NY; Addo KK; Jackson-Sillah D
    Int J Mycobacteriol; 2017; 6(1):27-33. PubMed ID: 28317801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients.
    Ryu MR; Park MS; Cho EH; Jung CW; Kim K; Kim SJ; Oh HY; Huh W; Jang HR; Koh WJ; Park HY; Kim YH; Sinn DH; Choi JO; Joh JW; Kim JM; Kim SJ; Park JB; Kang ES
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30135226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Routine Quantiferon Testing on Latent Tuberculosis Diagnosis and Treatment in Refugees in Multnomah County, Oregon, November 2009-October 2012.
    Walters JK; Sullivan AD
    J Immigr Minor Health; 2016 Apr; 18(2):292-300. PubMed ID: 25784140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
    Jeremiah K; Lyimo E; Ritz C; PrayGod G; Rutkowski KT; Korsholm KS; Ruhwald M; Tait D; Grewal HMS; Faurholt-Jepsen D
    PLoS One; 2021; 16(6):e0252808. PubMed ID: 34097715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and incidence of latent tuberculosis infection in georgian healthcare workers.
    Whitaker JA; Mirtskhulava V; Kipiani M; Harris DA; Tabagari N; Kempker RR; Blumberg HM
    PLoS One; 2013; 8(3):e58202. PubMed ID: 23536789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal screening for latent and active tuberculosis (TB) in asylum seeking children, Bochum and Hamburg, Germany, September 2015 to November 2016.
    Mueller-Hermelink M; Kobbe R; Methling B; Rau C; Schulze-Sturm U; Auer I; Ahrens F; Brinkmann F
    Euro Surveill; 2018 Mar; 23(12):. PubMed ID: 29589578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis among asylum seekers in Milan, Italy: epidemiological analysis and evaluation of interventions.
    Villa S; Codecasa LR; Faccini M; Pontello MM; Ferrarese M; Castellotti PF; Senatore S; Lamberti A; Mazzola E; Perno CF; Campisi D; Saporiti M; Raviglione MC
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31413161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Universal Screening Necessary? Incidence of Tuberculosis among Tibetan Refugees Arriving in Calgary, Alberta.
    Lim R; Jarand J; Field SK; Fisher D
    Can Respir J; 2016; 2016():8249843. PubMed ID: 28127230
    [No Abstract]   [Full Text] [Related]  

  • 14. First data on latent tuberculosis infection in Syrian refugees with diabetes in Lebanon.
    Ismail MB; Nour D; Raad G; Osman M; Rafei R; Mallat H; Dabboussi F; Hamze M
    Public Health; 2020 Dec; 189():97-100. PubMed ID: 33197733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmatic impact of QuantiFERON-TB Gold In-Tube implementation on latent tuberculosis diagnosis and treatment in a public health clinic.
    Shah M; DiPietro D; Greenbaum A; Ketemepi S; Martins-Evora M; Marsiglia V; Dorman SE
    PLoS One; 2012; 7(5):e36551. PubMed ID: 22586476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.
    Theel ES; Hilgart H; Breen-Lyles M; McCoy K; Flury R; Breeher LE; Wilson J; Sia IG; Whitaker JA; Clain J; Aksamit TR; Escalante P
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain.
    Calzada-Hernández J; Anton J; Martín de Carpi J; López-Montesinos B; Calvo I; Donat E; Núñez E; Blasco Alonso J; Mellado MJ; Baquero-Artigao F; Leis R; Vegas-Álvarez AM; Medrano San Ildefonso M; Pinedo-Gago MDC; Eizaguirre FJ; Tagarro A; Camacho-Lovillo M; Pérez-Gorricho B; Gavilán-Martín C; Guillén S; Sevilla-Pérez B; Peña-Quintana L; Mesa-Del-Castillo P; Fortuny C; Tebruegge M; Noguera-Julian A
    Eur J Pediatr; 2023 Jan; 182(1):307-317. PubMed ID: 36335186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent tuberculosis may be missed by current screening practices: Analysis of interferon-gamma release assay results from a paediatric refugee clinic.
    Colgan K; Anderson J; Maycock A; Britton PN; Mackenzie M; Isaacs D; Gunasekera H
    J Paediatr Child Health; 2019 Jul; 55(7):826-832. PubMed ID: 30565764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cost-benefit analysis of a proposed overseas refugee latent tuberculosis infection screening and treatment program.
    Wingate LT; Coleman MS; de la Motte Hurst C; Semple M; Zhou W; Cetron MS; Painter JA
    BMC Public Health; 2015 Dec; 15():1201. PubMed ID: 26627449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube tests for patients with active and latent tuberculosis: A prospective cohort study.
    Lee JK; Lee HW; Heo EY; Yim JJ; Kim DK
    J Infect Chemother; 2021 Dec; 27(12):1694-1699. PubMed ID: 34412980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.